Agreed Bangs revenue is low as we probably negotiated too well and they had to price their products too high.
But I still beleive the Merck deal has more to it and we will find out more this year.
Will be intersting weeks/months ahead if we get further exposure through an updated broker report or an insto/fund wanting in.
Or just more signings
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $37.87M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.3¢ | $28.37K | 2.186M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 2626989 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 1929751 | 7 |
View Market Depth
| Last trade - 16.10pm 07/07/2025 (20 minute delay) ? |
| ADO (ASX) Chart |